These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 37108506)
21. [The use of accommodative lenses for surgical correction of the presbyopia using the Prelex method]. Urminský J; Rozsíval P; Lorencová V; Feuermannová A Cesk Slov Oftalmol; 2006 Sep; 62(5):324-33. PubMed ID: 17039919 [TBL] [Abstract][Full Text] [Related]
22. Glycation and insolubility of human lens protein. Kamei A Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2787-91. PubMed ID: 1464110 [TBL] [Abstract][Full Text] [Related]
23. Increased levels of advanced glycation end products in human cataractous lenses. Franke S; Dawczynski J; Strobel J; Niwa T; Stahl P; Stein G J Cataract Refract Surg; 2003 May; 29(5):998-1004. PubMed ID: 12781289 [TBL] [Abstract][Full Text] [Related]
24. Living with presbyopia: experiences from a virtual roundtable dialogue among impacted individuals and healthcare professionals. Brujic M; Kruger P; Todd J; Barnes E; Wuttke M; Perna F; Aliò J BMC Ophthalmol; 2022 May; 22(1):204. PubMed ID: 35513787 [TBL] [Abstract][Full Text] [Related]
25. Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract. Hashim Z; Zarina S Age (Dordr); 2011 Sep; 33(3):377-84. PubMed ID: 20842534 [TBL] [Abstract][Full Text] [Related]
26. Quercetin inhibited epithelial mesenchymal transition in diabetic rats, high-glucose-cultured lens, and SRA01/04 cells through transforming growth factor-β2/phosphoinositide 3-kinase/Akt pathway. Du L; Hao M; Li C; Wu W; Wang W; Ma Z; Yang T; Zhang N; Isaac AT; Zhu X; Sun Y; Lu Q; Yin X Mol Cell Endocrinol; 2017 Sep; 452():44-56. PubMed ID: 28501572 [TBL] [Abstract][Full Text] [Related]
27. Protein Disulfide Levels and Lens Elasticity Modulation: Applications for Presbyopia. Garner WH; Garner MH Invest Ophthalmol Vis Sci; 2016 May; 57(6):2851-63. PubMed ID: 27233034 [TBL] [Abstract][Full Text] [Related]
28. 2-ammonio-6-(3-oxidopyridinium-1-yl)hexanoate (OP-lysine) is a newly identified advanced glycation end product in cataractous and aged human lenses. Argirov OK; Lin B; Ortwerth BJ J Biol Chem; 2004 Feb; 279(8):6487-95. PubMed ID: 14634019 [TBL] [Abstract][Full Text] [Related]
29. Transient elevation of temperature promotes cross-linking of α-crystallin-client proteins through formation of advanced glycation endproducts: A potential role in presbyopia and cataracts. Nandi SK; Rankenberg J; Glomb MA; Nagaraj RH Biochem Biophys Res Commun; 2020 Dec; 533(4):1352-1358. PubMed ID: 33081971 [TBL] [Abstract][Full Text] [Related]
30. [TREATMENTS FOR PRESBYOPIA]. Erdinest N; Morad Y; London N; Shmueli O; Lavy I Harefuah; 2022 Jul; 161(7):448-453. PubMed ID: 35833432 [TBL] [Abstract][Full Text] [Related]
31. The ageing lens and cataract: a model of normal and pathological ageing. Michael R; Bron AJ Philos Trans R Soc Lond B Biol Sci; 2011 Apr; 366(1568):1278-92. PubMed ID: 21402586 [TBL] [Abstract][Full Text] [Related]
32. Presbyopia correction with an anterior chamber phakic multifocal intraocular lens. Alió JL; Mulet ME Ophthalmology; 2005 Aug; 112(8):1368-74. PubMed ID: 16023215 [TBL] [Abstract][Full Text] [Related]
33. Developments in the correction of presbyopia I: spectacle and contact lenses. Charman WN Ophthalmic Physiol Opt; 2014 Jan; 34(1):8-29. PubMed ID: 24205890 [TBL] [Abstract][Full Text] [Related]
34. Separation of the yellow chromophores in individual brunescent cataracts. Cheng R; Lin B; Ortwerth BJ Exp Eye Res; 2003 Sep; 77(3):313-25. PubMed ID: 12907164 [TBL] [Abstract][Full Text] [Related]
35. Aging and age-related diseases of the ocular lens and vitreous body. Petrash JM Invest Ophthalmol Vis Sci; 2013 Dec; 54(14):ORSF54-9. PubMed ID: 24335070 [TBL] [Abstract][Full Text] [Related]
36. [Comparison of visual acuity in pseudophakic eyes with multifocal intraocular lens versus fellow eyes with clear lens]. Li JH; Zhao YE; Huang F; Zhao YY; Zheng JW Zhonghua Yan Ke Za Zhi; 2010 Aug; 46(8):691-6. PubMed ID: 21054992 [TBL] [Abstract][Full Text] [Related]
37. Promotion of Protein Solubility and Reduction in Stiffness in Human Lenses by Aggrelyte-1: Implications for Reversing Presbyopia. Panja S; Gaikwad H; Rankenberg J; Nam MH; Nagaraj RH Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768517 [TBL] [Abstract][Full Text] [Related]
38. Similarity of the yellow chromophores isolated from human cataracts with those from ascorbic acid-modified calf lens proteins: evidence for ascorbic acid glycation during cataract formation. Cheng R; Lin B; Lee KW; Ortwerth BJ Biochim Biophys Acta; 2001 Jul; 1537(1):14-26. PubMed ID: 11476959 [TBL] [Abstract][Full Text] [Related]
39. [Phakic intraocular lens for presbyopia correction]. Ferraz CA; Allemann N; Chamon W Arq Bras Oftalmol; 2007; 70(4):603-8. PubMed ID: 17906755 [TBL] [Abstract][Full Text] [Related]
40. Polymer refilling of presbyopic human lenses in vitro restores the ability to undergo accommodative changes. Koopmans SA; Terwee T; Barkhof J; Haitjema HJ; Kooijman AC Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):250-7. PubMed ID: 12506082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]